A detailed history of Crossmark Global Holdings, Inc. transactions in Galapagos Nv stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 37,386 shares of GLPG stock, worth $1.02 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
37,386
Holding current value
$1.02 Million
% of portfolio
0.02%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$24.2 - $30.67 $904,741 - $1.15 Million
37,386 New
37,386 $1.08 Million
Q2 2021

Jul 21, 2021

SELL
$68.86 - $83.34 $377,077 - $456,369
-5,476 Closed
0 $0
Q1 2021

Apr 15, 2021

SELL
$76.15 - $111.94 $1,827 - $2,686
-24 Reduced 0.44%
5,476 $422,000
Q4 2020

Jan 14, 2021

BUY
$96.85 - $148.25 $51,330 - $78,572
530 Added 10.66%
5,500 $544,000
Q3 2020

Oct 08, 2020

BUY
$122.47 - $213.56 $35,516 - $61,932
290 Added 6.2%
4,970 $705,000
Q2 2020

Aug 14, 2020

BUY
$185.52 - $231.25 $54,542 - $67,987
294 Added 6.7%
4,680 $923,000
Q1 2020

Apr 28, 2020

BUY
$143.0 - $274.03 $67,210 - $128,794
470 Added 12.0%
4,386 $859,000
Q4 2019

Feb 06, 2020

SELL
$146.12 - $215.82 $29,808 - $44,027
-204 Reduced 4.95%
3,916 $810,000
Q3 2019

Oct 09, 2019

BUY
$130.44 - $187.64 $537,412 - $773,076
4,120 New
4,120 $629,000

Others Institutions Holding GLPG

About GALAPAGOS NV


  • Ticker GLPG
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,835,500
  • Market Cap $1.79B
  • Description
  • Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...
More about GLPG
Track This Portfolio

Track Crossmark Global Holdings, Inc. Portfolio

Follow Crossmark Global Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.